This study is looking at a new device called ReneuRx™ for people with moderate to severe chronic lateral hip pain (pain on the outside of the hip). It will compare ReneuRx™ to a common treatment, a single injection of Triamcinolone acetate (a steroid) into the hip joint. ReneuRx™ will be injected around specific nerves in the hip. The study wants to see how safe ReneuRx™ is and how well it helps with pain. You might be able to join if you are between 22 and 80 years old, have significant hip pain despite current treatments, and tenderness in the hip area. The study will follow participants for about 6 to 12 months to see how they are doing. The current status of this study is unclear.

Study design

This is an interventional study with a planned enrollment of 100 participants. It compares the ReneuRx™ device to Triamcinolone acetate injections.

What's involved

You would attend study visits, complete quality of life questionnaires, and be followed for approximately 6-12 months after the study procedure.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for approximately 6-12 months after the study procedure, with safety measured through study completion (an average of 12 months).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.